Form 8-K · Current report
McCormick & Company 8-K, filed Aug 28, 2026
- Filed
- CIK
- 0000063754
- Accession no.
- 0000063754-26-000305
Summary
Anne Bramman has told McCormick & Company's board she intends to resign from it, effective November 30, 2026, citing her recent appointment as Executive Vice President and Chief Financial Officer of Best Buy. She will step down as Audit Committee chair on September 1, 2026, with board member Valarie Sheppard taking that role, and remain on the board and committee until her resignation.
Key points
- Bramman's resignation is not due to any disagreement with McCormick over its operations, policies, or practices.
- Bramman will step down as Audit Committee chair effective September 1, 2026.
- Valarie Sheppard, a current board and Audit Committee member, becomes Audit Committee chair effective September 1, 2026.
- Bramman remains a board and Audit Committee member until her resignation takes effect November 30, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 25, 2026, Anne Bramnan, a member of the Board of Directors (the “Board”) of McCormick & Company, Incorporated (the “Company”) and the Chair of the Audit Committee of the Board, informed the Board that she intends to resign from the Board. Ms. Bramman’s decision to resign from the Company’s Board is due to her recent appointment as Executive Vice President and Chief Financial Officer of Best Buy Co., Inc. (NYSE:BBY) and the time commitments which such position will require. To support an orderly transition, Ms. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.